Skip to main content

Table 3 Demographic, clinical and biochemical data of two patients with already diagnosed type 1 diabetes admitted to pediatric intensive care unit for severe secondary diabetic ketoacidosis

From: Prevalence and clinical features of severe diabetic ketoacidosis treated in pediatric intensive care unit: a 5-year monocentric experience

 

Patient 1

Patient 2

Age (years)

13.3

6.5

Gender

Female

Female

Height (Z-score)

-0.75

-1.46

Weight (Z-score)

-2.10

-2.30

BMI (Z-score)

-1.96

-1.94

Family history of T1D (1st degree)

No

Unknown

Low household income

Yes

Yes

Immigrant background

Yes

Yes

Clinical presentation

 Kussmaul’s breathing

Yes

Yes

 Polyuria and polydipsia

Yes

No

 Gastrointestinal symptoms

Yes

No

 Severe neurological impairment (GCS < 9)

No

Yes

 Moderate neurological impairment (GCS between 9 and 13)

No

No

Biochemical data

 Blood glucose at admission (mg/dl)

750

698

 Venous pH

6.80

6.83

 Serum bicarbonate (mmol/L)

5.6

3.0

 Base excess (mmol/L)

-31

Unknown

 BUN (mg/dl)

74

109

 Serum creatinine (mg/dl)

1.3

1.2

 Serum potassium (mg/dl)

6.2

3.4

 HbA1c (%)

8.1

7.6

DKA treatment

 Duration of DKA treatment (hours)

96

48

 Bicarbonate administration

No

No

Outcomes

 Acute kidney injury

No

Yes

 Cerebral edema

No

Yes

 MOF

No

Yes

 Mortality

No

No

  1. BMI Body mass index, BUN Blood urea nitrogen, DKA Diabetic ketoacidosis, GCS Glasgow coma scale, HbA1c Glycated hemoglobin, MOF Multiple organ failure, PICU Pediatric intensive care unit, T1D Type 1 diabetes